Hepatoma Research Receives a 2025 Impact Factor of 1.8

Clarivate released the 2025 Journal Citation Reports (JCR) on June 17, 2026. We are pleased to announce that Hepatoma Research has received a 2025 Journal Impact Factor (JIF) of 1.8.

We would like to express our sincere gratitude to our Editorial Board members, Guest Editors, authors, reviewers, and readers worldwide for their continued support and valuable contributions.

Hepatoma Research remains committed to serving as an open-access platform for disseminating innovative research and clinical advances, and we look forward to further serving the global hepatology and oncology communities.

Editor: Vivienne Yan
Language Editor: Amir Khan
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Hepatoma Research